BIOMAT Database Logo BIOMAT Database Logo

Fasciitis in mixed connective tissue disease successfully treated with high-dose intravenous immunoglobulin. 2003

Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
Department of Neurology, Saku Central Hospital, Usuda.

UI MeSH Term Description Entries
D008947 Mixed Connective Tissue Disease A syndrome with overlapping clinical features of systemic lupus erythematosus, scleroderma, polymyositis, and Raynaud's phenomenon. The disease is differentially characterized by high serum titers of antibodies to ribonuclease-sensitive extractable (saline soluble) nuclear antigen and a "speckled" epidermal nuclear staining pattern on direct immunofluorescence. Connective Tissue Disease, Mixed,Sharp Syndrome,MCTD,Syndrome, Sharp
D005208 Fasciitis Inflammation of the fascia. There are three major types: 1, Eosinophilic fasciitis, an inflammatory reaction with eosinophilia, producing hard thickened skin with an orange-peel configuration suggestive of scleroderma and considered by some a variant of scleroderma; 2, Necrotizing fasciitis (FASCIITIS, NECROTIZING), a serious fulminating infection (usually by a beta hemolytic streptococcus) causing extensive necrosis of superficial fascia; 3, Nodular/Pseudosarcomatous /Proliferative fasciitis, characterized by a rapid growth of fibroblasts with mononuclear inflammatory cells and proliferating capillaries in soft tissue, often the forearm; it is not malignant but is sometimes mistaken for fibrosarcoma. Fascitis,Fasciitides,Fascitides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016756 Immunoglobulins, Intravenous Immunoglobulin preparations used in intravenous infusion, containing primarily IMMUNOGLOBULIN G. They are used to treat a variety of diseases associated with decreased or abnormal immunoglobulin levels including pediatric AIDS; primary HYPERGAMMAGLOBULINEMIA; SCID; CYTOMEGALOVIRUS infections in transplant recipients, LYMPHOCYTIC LEUKEMIA, CHRONIC; Kawasaki syndrome, infection in neonates, and IDIOPATHIC THROMBOCYTOPENIC PURPURA. Antibodies, Intravenous,Human Intravenous Immunoglobulin,IV Immunoglobulin,IVIG,Intravenous Antibodies,Intravenous Immunoglobulin,Intravenous Immunoglobulins,Alphaglobin,Endobulin,Flebogamma DIF,Gamimmune,Gamimmune N,Gamimune,Gamimune N,Gammagard,Gammonativ,Gamunex,Globulin-N,IV Immunoglobulins,Immune Globulin Intravenous (Human),Immune Globulin, Intravenous,Immunoglobulins, Intravenous, Human,Intraglobin,Intraglobin F,Intravenous IG,Intravenous Immunoglobulins, Human,Iveegam,Modified Immune Globulin (Anti-Echovirus Antibody),Privigen,Sandoglobulin,Venimmune,Venoglobulin,Venoglobulin-I,Globulin N,Human Intravenous Immunoglobulins,Immunoglobulin, Human Intravenous,Immunoglobulin, IV,Immunoglobulin, Intravenous,Immunoglobulins, Human Intravenous,Immunoglobulins, IV,Intravenous Immune Globulin,Intravenous Immunoglobulin, Human,Venoglobulin I
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
Solar urticaria treated successfully with intravenous high-dose immunoglobulin: a case report.
December 2008, Photodermatology, photoimmunology & photomedicine,
Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
Efficacy of pulsed intravenous immunoglobulin therapy in mixed connective tissue disease.
January 2002, Journal of the American Academy of Dermatology,
Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
Intravenous Immunoglobulin for Mixed Connective Tissue Disease Presenting With Bilateral Trigeminal Neuropathy.
January 2018, American journal of therapeutics,
Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin.
May 1985, Lancet (London, England),
Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
[A case of mixed connective tissue disease successfully treated for hemophagocytic syndrome with intermittent intravenous injection of cyclophosphamide].
October 2004, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology,
Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
[A case of primary erythromelalgia successfully treated with high-dose intravenous immunoglobulin therapy].
February 2014, Brain and nerve = Shinkei kenkyu no shinpo,
Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
Fulminant myocarditis successfully treated with high-dose immunoglobulin.
September 2004, International journal of cardiology,
Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
"Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
September 2012, Acta dermatovenerologica Alpina, Pannonica, et Adriatica,
Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
Experience with monthly, high-dose, intravenous immunoglobulin therapy in patients with different connective tissue diseases.
April 2005, Rheumatology international,
Masayuki Matsuda, and Jun Miki, and Kenya Oguchi, and Kenichi Tabata, and Shu-ichi Ikeda
Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis.
November 1991, Annals of the rheumatic diseases,
Copied contents to your clipboard!